Evidence map›Paper›PMID 25077541›Full record

ArticleCell death & disease2014

miR-17 extends mouse lifespan by inhibiting senescence signaling mediated by MKP7.

W W Du, W Yang, L Fang, J Xuan, H Li, A Khorshidi, S Gupta, X Li, B B Yang

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Noncoding RNA Contribution to Aging and Lifespan.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  9. Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  10. Article
  11. Review
  12. Genomic Instability and Epigenetic Changes during Aging.International journal of molecular sciences · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

W W Du1] Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
W YangSunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.
L Fang1] Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
J XuanSunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada.
H Li1] Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
A Khorshidi1] Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
S Gupta1] Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
X Li1] Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada [3] Guangdong Institute of Microbiology, Guangzhou, China.
B B Yang1] Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Health Sciences Centre · CASunnybrook Health Science Centre · CASunnybrook Research InstituteUniversity of Toronto · CA

Funding

Canadian Institutes of Health Research MOP-102635Canadian Institutes of Health Research MOP-111171
6 · The paper itself

Abstract

Here we show that transgenic expression of miR-17 extends lifespan and inhibits cellular senescence. We propose that miR-17 acts as a critical regulator of cellular senescence and tumorigenesis. We demonstrate that miR-17 targets both ADCY5 and IRS1, upregulating the downstream signals MKP7, FoxO3, LC3B, and HIF1α, and downregulating mTOR, c-myc, cyclin D1, and JNK. Silencing either ADCY5 or IRS1 promoted autophagy and repressed cellular senescence and apoptosis. Repression of ADCY5 by miR-17 translocated membrane-bound RGS2 into the nucleus, promoting interactions of RGS2 with HIF1α and the MKP7 promoter, enhancing MKP7 transcription. ADCY5 repression by miR-17 also facilitated the translocation of EGFR and MKP7 from membrane into cytoplasmic and mitochondrial fractions. Importantly, we found that MKP7 inhibited senescence by dephosphorylating PRAS40 at Thr246 and mTOR at Ser2248, facilitating the interaction and loss of function of both molecules. Thus, the oncogenic miR-17 also acts pleiotropically to inhibit cellular senescence and extend longevity.

Indexed as

Cellular SenescenceLongevitySignal TransductionAdenylyl CyclasesAnimalsDual-Specificity PhosphatasesInsulin Receptor Substrate ProteinsMiceMice, TransgenicMicroRNAsMitogen-Activated Protein Kinase PhosphatasesPromoter Regions, GeneticProtein BindingProtein TransportAdenylyl Cyclasesadenylyl cyclase type VDual-Specificity PhosphatasesDusp16 protein, mouseInsulin Receptor Substrate ProteinsIrs1 protein, mouseMicroRNAsMirn17 microRNA, mouseMitogen-Activated Protein Kinase Phosphatases

Identifiers

PMID25077541
PMCPMC4123096
OpenAlexW2040519360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.